Titleist Asset Management LLC Has $1.43 Million Stock Holdings in Core Scientific, Inc. (NASDAQ:CORZ)

Titleist Asset Management LLC lowered its stake in shares of Core Scientific, Inc. (NASDAQ:CORZ) by 44.5% during the 4th quarter, Holdings Channel.com reports. The firm owned 101,725 shares of the company’s stock after selling 81,626 shares during the quarter. Titleist Asset Management LLC’s holdings in Core Scientific were worth $1,429,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in CORZ. Vanguard Group Inc. raised its stake in Core Scientific by 54.3% during the 4th quarter. Vanguard Group Inc. now owns 19,378,652 shares of the company’s stock worth $272,270,000 after buying an additional 6,819,406 shares during the period. ORG Wealth Partners LLC raised its position in shares of Core Scientific by 0.3% during the fourth quarter. ORG Wealth Partners LLC now owns 8,986,651 shares of the company’s stock worth $126,262,000 after purchasing an additional 26,649 shares during the period. Helix Partners Management LP bought a new position in shares of Core Scientific in the 4th quarter worth $86,498,000. Geode Capital Management LLC grew its position in Core Scientific by 4.9% in the 4th quarter. Geode Capital Management LLC now owns 5,532,715 shares of the company’s stock valued at $77,756,000 after purchasing an additional 256,142 shares during the period. Finally, State Street Corp increased its stake in Core Scientific by 17.0% during the 3rd quarter. State Street Corp now owns 4,006,922 shares of the company’s stock valued at $47,522,000 after purchasing an additional 583,493 shares in the last quarter.

Analyst Ratings Changes

CORZ has been the topic of a number of recent research reports. BTIG Research raised their price objective on shares of Core Scientific from $19.00 to $20.00 and gave the company a “buy” rating in a research note on Monday, December 16th. Compass Point cut their price target on Core Scientific from $26.00 to $20.00 and set a “buy” rating for the company in a research note on Tuesday, February 25th. HC Wainwright reissued a “buy” rating and issued a $17.00 price objective on shares of Core Scientific in a research note on Tuesday, March 11th. Needham & Company LLC dropped their target price on Core Scientific from $18.00 to $17.00 and set a “buy” rating on the stock in a report on Thursday, February 27th. Finally, Keefe, Bruyette & Woods assumed coverage on Core Scientific in a report on Monday, January 27th. They set an “outperform” rating and a $22.00 price target for the company. Fifteen equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $19.07.

Core Scientific Stock Performance

Shares of NASDAQ:CORZ opened at $7.18 on Friday. Core Scientific, Inc. has a fifty-two week low of $2.61 and a fifty-two week high of $18.63. The company’s 50-day moving average is $10.07 and its 200 day moving average is $12.99. The company has a market capitalization of $2.12 billion, a P/E ratio of -1.33 and a beta of 6.80.

Core Scientific (NASDAQ:CORZ) last released its earnings results on Wednesday, February 26th. The company reported ($0.01) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.09. The company had revenue of $94.93 million for the quarter, compared to the consensus estimate of $97.07 million. As a group, research analysts predict that Core Scientific, Inc. will post 0.52 earnings per share for the current year.

Insider Buying and Selling at Core Scientific

In other news, CEO Adam Taylor Sullivan sold 369,712 shares of the company’s stock in a transaction on Friday, January 24th. The stock was sold at an average price of $16.24, for a total transaction of $6,004,122.88. Following the transaction, the chief executive officer now owns 3,758,793 shares of the company’s stock, valued at $61,042,798.32. This represents a 8.96 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Todd A. Becker sold 134,250 shares of Core Scientific stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $10.75, for a total value of $1,443,187.50. Following the completion of the sale, the director now directly owns 195,687 shares of the company’s stock, valued at approximately $2,103,635.25. This trade represents a 40.69 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 530,041 shares of company stock valued at $7,870,352. Company insiders own 32.00% of the company’s stock.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.